Shares of Nashville-based eye care pharmaceutical company Harrow Health hit a 52-week high on Monday. 

The stock traded as high as $44.37, after having traded at a previous high mark of $44.14, with a volume of about 403,000 shares late in the session. At the end of trading on Monday, it was 44.22.

Recommended for you